IDH1 and glioblastoma: Here we identify ‘active’ LOC–DHX15 RNP complex as a targetable vulnerability in IDH-wild-type glioblastoma, which suggests that targeting this RNA–RBP interaction could also be useful for designing next generation drugs for this deadly cancer.